BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11872198)

  • 1. Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women.
    Farzati A; Esposito K; Colacurci N; Fornaro F; Chiantera V; Farzati B
    Fertil Steril; 2002 Mar; 77(3):476-80. PubMed ID: 11872198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
    Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
    Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women.
    Sumino H; Ichikawa S; Ohyama Y; Takahashi T; Saito Y; Nakamura T; Kanda T; Kurabayashi M
    Am J Cardiol; 2005 Jul; 96(1):148-53. PubMed ID: 15979455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin and endothelial markers in postmenopausal women taking oral or transdermal hormone therapy.
    Ruszkowska B; Sokup A; Kulwas A; Kwapisz J; Góralczyk K; Socha MW; Rhone P; Rość D
    Acta Obstet Gynecol Scand; 2013 Jul; 92(7):841-6. PubMed ID: 23472599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women.
    Koh KK; Bui MN; Mincemoyer R; Cannon RO
    Am J Cardiol; 1997 Dec; 80(11):1505-7. PubMed ID: 9399737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
    Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
    Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
    Eilertsen AL; Høibraaten E; Os I; Andersen TO; Sandvik L; Sandset PM
    Maturitas; 2005 Oct; 52(2):111-8. PubMed ID: 16186073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women.
    Cicinelli E; Ranieri G; Maffei S; Colafiglio G; Ria R; Bellavia M; Schonauer MM
    Fertil Steril; 2006 Oct; 86(4):899-904. PubMed ID: 16963035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
    Os I; Os A; Sandset PM; Bølling S; Seljeflot I; Djurovic S; Westheim A
    Cardiology; 2002; 98(1-2):6-12. PubMed ID: 12373040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia.
    Blum A; Lang N; Peleg A; Vigder F; Israeli P; Gumanovsky M; Lupovitz S; Elgazi A; Ben-Ami M
    Am Heart J; 2003 Feb; 145(2):e7. PubMed ID: 12595862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of soy isoflavones on endothelial function in healthy postmenopausal women.
    Colacurci N; Chiàntera A; Fornaro F; de Novellis V; Manzella D; Arciello A; Chiàntera V; Improta L; Paolisso G
    Menopause; 2005; 12(3):299-307. PubMed ID: 15879919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women.
    Goudev A; Georgiev DB; Koycheva N; Manasiev N; Kyurkchiev S
    Maturitas; 2002 Sep; 43(1):49-53. PubMed ID: 12270582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women.
    Stomati M; Bersi C; Rubino S; Palumbo M; Comitini G; Genazzani AD; Santuz M; Petraglia F; Genazzani AR
    Maturitas; 1997 Dec; 28(2):127-35. PubMed ID: 9522320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.
    Ylikorkala O; Cacciatore B; Paakkari I; Tikkanen MJ; Viinikka L; Toivonen J
    Fertil Steril; 1998 May; 69(5):883-8. PubMed ID: 9591497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of transdermal hormone replacement therapy on carotid artery wall thickness and levels of vascular inflammatory markers in postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Kumakura H; Takayama Y; Sakamaki T; Kurabayashi M
    Hypertens Res; 2005 Jul; 28(7):579-84. PubMed ID: 16335886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral and transdermal estrogen therapies on circulating cytokines and chemokines in postmenopausal women with hysterectomy.
    Yasui T; Saijo A; Uemura H; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
    Eur J Endocrinol; 2009 Aug; 161(2):267-73. PubMed ID: 19451213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women.
    Hemelaar M; van der Mooren MJ; van Baal WM; Schalkwijk CG; Kenemans P; Stehouwer CD
    Menopause; 2005; 12(5):526-35. PubMed ID: 16145306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages.
    Coskun U; Sancak B; Sen I; Bukan N; Tufan MA; Gülbahar O; Sozen S
    Int Immunopharmacol; 2006 Apr; 6(4):672-7. PubMed ID: 16504931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women.
    Song Y; Manson JE; Tinker L; Rifai N; Cook NR; Hu FB; Hotamisligil GS; Ridker PM; Rodriguez BL; Margolis KL; Oberman A; Liu S
    Diabetes; 2007 Jul; 56(7):1898-904. PubMed ID: 17389327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.